[A11-29] Aliskiren/amlodipine (combination of active ingredients) - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Last updated 15.02.2012
Project no.:
A11-29
Commission:
Commission awarded on 14.11.2011 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Heart and circulation
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A11-09 | Aliskiren/amlodipine (combination of active ingredients) - Consultation on the content and completeness of the dossier | Commission completed |
Federal Joint Committee (G-BA)
2012-05-03 A G-BA decision was published.